Qualitative and quantitative measures of various compounded formulations of 17-alpha hydroxyprogesterone caproate. [PDF]
Caritis SN +3 more
europepmc +1 more source
The influence of prior obstetrical history on current 17-hydroxyprogesterone caproate use. [PDF]
Ransom CE +5 more
europepmc +1 more source
Progesterone Metabolites Produced by Cytochrome P450 3A Modulate Uterine Contractility in a Murine Model. [PDF]
Patil AS +5 more
europepmc +1 more source
What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth. [PDF]
Caritis SN +4 more
europepmc +1 more source
Quality assessment of compounded 17-hydroxyprogesterone caproate. [PDF]
Chang J +5 more
europepmc +1 more source
Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention. [PDF]
Manuck TA +7 more
europepmc +1 more source
Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth. [PDF]
Manuck TA +13 more
europepmc +1 more source
Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations. [PDF]
Feghali M, Venkataramanan R, Caritis S.
europepmc +1 more source
Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency.
Turcu AF +9 more
europepmc +1 more source

